FAPA 2020

FAPA

FAPA (The Federation of Asian Pharmaceutical Associations), formed in 1964, aims to be the leading international pharmacy organization, guiding Asian pharmacists and pharmacy organizations to achieve professional excellence, and contribute towards making medicines safe, effective, accessible and affordable, thus, ensuring optimum health outcomes.

FAPA stands by the following missions:

  1. to  develop and advance pharmaceutical professionalism in Asia by upholding and safeguarding the rights of pharmacists, promoting cooperation between national, regional and Asian societies or associations which aim at the advancement of the individual pharmacists as professionals;
  2. To improve healthcare system in member countries; and 
  3. To enable pharmaceutical professionals in Asia to contribute to the development of pharmaceutical professionalism internationally.

To get a better understanding of FAPA’s values and mission, their official website is found right here.

FAPA Congress

The FAPA Congress is a biennial event held under the flagship of FAPA. Attended by members from the Eastern Meditteranean, Southeast Asian and Western Pacific Region, FAPA  Congress provides the focal hub for its members to meet, exchange ideas and generate new findings. 

Each Congress provides an avenue for the sharing of expertise; presentation of new developments or discoveries; learning of new strategies; networking with pharmacists from other organizations/countries.

For more information on FAPA and FAPA Congress, please refer to Article 25 of the FAPA Constitution here

FAPA Congress In Malaysia

The year 2020 will be the third occasion Malaysia hosts this prestigious event since the inception of the Malaysian Pharmaceutical Society in 1967. The previous two times were both held in Kuala Lumpur, in 1996 and 2014. 

With the theme “Pharmacists Building a Better Healthcare System”, the FAPA Congress 2020 intends to look at the role of pharmacists that have contributed to the advancements of healthcare through the ages, as well as to opportunities to continue to building an inclusive, effective, technologically robust healthcare system that accommodates the individual needs while maintaining an affordable price tag.